TWIST BIOSCIENCE CORP's ticker is TWST and the CUSIP is 90184D100. A total of 240 filers reported holding TWIST BIOSCIENCE CORP in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16,762,240 | -32.4% | 704,000 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $24,809,000 | +0.8% | 704,000 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $24,612,000 | -89.6% | 704,000 | -85.3% | 0.01% | -87.8% |
| Q1 2022 | $236,819,000 | -32.3% | 4,795,848 | +6.0% | 0.04% | -25.5% |
| Q4 2021 | $350,012,000 | -24.6% | 4,522,700 | +4.2% | 0.06% | -30.4% |
| Q3 2021 | $464,252,000 | -23.0% | 4,340,016 | -4.0% | 0.08% | -22.5% |
| Q2 2021 | $602,649,000 | +45.5% | 4,522,692 | +35.3% | 0.10% | +32.5% |
| Q1 2021 | $414,079,000 | -0.6% | 3,343,124 | +13.4% | 0.08% | -3.8% |
| Q4 2020 | $416,703,000 | +240.7% | 2,949,272 | +83.2% | 0.08% | +196.3% |
| Q3 2020 | $122,308,000 | +283.5% | 1,609,952 | +128.7% | 0.03% | +237.5% |
| Q2 2020 | $31,891,000 | +48.1% | 704,000 | 0.0% | 0.01% | +33.3% |
| Q1 2020 | $21,528,000 | +45.6% | 704,000 | 0.0% | 0.01% | +100.0% |
| Q4 2019 | $14,784,000 | – | 704,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 1,104,214 | $156,015,000 | 38.36% |
| Blue Water Life Science Advisors, LP | 146,356 | $20,678,000 | 6.16% |
| Casdin Capital, LLC | 1,000,000 | $141,290,000 | 4.19% |
| BRANDYWINE MANAGERS, LLC | 18,988 | $2,683,000 | 3.69% |
| Capital Impact Advisors, LLC | 97,000 | $13,705,000 | 3.36% |
| Brevan Howard Capital Management LP | 112,000 | $15,824,000 | 3.17% |
| ARK Investment Management | 5,876,971 | $830,357,000 | 2.21% |
| Nicholas Investment Partners, LP | 178,875 | $25,273,000 | 1.95% |
| Nikko Asset Management Americas, Inc. | 1,840,306 | $260,017,000 | 1.48% |
| Intellectus Partners, LLC | 28,058 | $3,964,000 | 1.19% |